News

Legislation Targeting Maternity Ward Closures Helps Families Seek Answers for Available Local Labor and Delivery Services, Says Consumer Watchdog

San Diego, Simi Valley, Latest to Face Closures SACRAMENTO, Calif., April 17, 2024 /PRNewswire/ — Assemblymember Akilah Weber’s bill, AB 1895 requiring the state to conduct community impact assessments before hospitals may close California maternity […]

News

Aspen Neuroscience Announces First Patient Dosed in First-in-Human Phase 1/2a Clinical Trial of Autologous Neuronal Cell Replacement Therapy for Parkinson’s Disease

First U.S. Multi-center, Multi-patient Phase 1/2a Trial of an Autologous Neurological Therapy SAN DIEGO, April 17, 2024 /PRNewswire/ — Aspen Neuroscience, Inc. announced that the first patient has been dosed in the ASPIRO trial, a […]

ADVERTISEMENT — Advertise With Biotech Networks
News

Lennox-Gastaut Syndrome (LGS) Foundation Announces Exciting New Research Funded in Time for the 9th Annual Walk ‘n’ Wheel for LGS Research

SAN DIEGO, April 16, 2024 /PRNewswire/ — On April 20, 2024, the Lennox-Gastaut Syndrome (LGS) Foundation will mobilize families, friends, and communities around the world to ‘Step Towards the Cures, Together’ at their 9th Annual […]

ADVERTISEMENT — Advertise With Biotech Networks
News

Investors who lost over $100,000 with Ventyx Biosciences, Inc. (NASDAQ: VTYX) between October 2021 to November 2023, should contact the Shareholders Foundation in connection with Lawsuit

SAN DIEGO, April 15, 2024 /PRNewswire/ — The Shareholders Foundation, Inc. announces that a deadline is coming up on April 30, 2024, in the lawsuit that was filed for certain investors in Ventyx Biosciences, Inc. […]

ADVERTISEMENT — Advertise With Biotech Networks
News

ImpediMed to Present Chronic Breast Cancer-related Lymphedema Study Results at American Society of Breast Surgeons Annual Meeting

New research shows patients at risk of developing breast cancer-related lymphedema should be monitored for minimum of three years following completion of cancer treatment CARLSBAD, Calif., April 11, 2024 /PRNewswire/ — ImpediMed, a leader in […]

News

Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA

Requested for Q2 2024, the Type C meeting is to focus on planned registration-enabling trial in HR+/HER2- metastatic breast cancer Overall survival results from the randomized HR+/HER2- metastatic breast cancer BRACELET-1 trial expected in H2 […]

News

Era Locums Wins Top Medical Staffing Award

SAN DIEGO, April 11, 2024 /PRNewswire/ — Era Locums, a fast-growing medical staffing company founded by industry veteran Sigrid Boring, is thrilled to announce it has been named one of Staffing Industry Analysts (SIA) Best […]

ADVERTISEMENT — Advertise With Biotech Networks
News

How a new drug prototype regenerates lung tissue

A new study from Scripps Research and Calibr-Skaggs scientists provides pharmacological proof of concept for an upcoming phase 1 clinical trial. LA JOLLA, Calif., April 10, 2024 /PRNewswire/ — Pulmonary diseases are a leading cause […]

ADVERTISEMENT — Advertise With Biotech Networks
News

Navigate BioPharma Services, Inc. announces collaboration with RareCyte, Inc. to provide enhanced spatial biology capabilities using the Orion™ Platform

CARLSBAD, Calif., April 9, 2024 /PRNewswire/ — Navigate BioPharma Services, Inc., a specialty laboratory offering high-quality, innovative precision medicine solutions and bioanalytics for clinical development and diagnostic applications announces the launch of its new multiplex […]

News

Model Medicines Unveils Groundbreaking AI Drug Discovery Advances in New Chemistry and New Biology with Two New Preprint Papers

LA JOLLA, Calif., April 9, 2024 /PRNewswire/ — Model Medicines, a leading human health company specializing in generative AI-driven drug discovery, today announced the publication of two significant preprint papers on bioRxiv detailing major advances […]

No Picture
News

GenFleet Therapeutics Announces Broad-spectrum Activity of GFH547, an Oral panRAS (ON) Inhibitor, and Its Potential to Overcome Resistance against SIIP-based KRAS Inhibitors in Late-breaking Research Abstract of 2024 AACR Annual Meeting

SHANGHAI and SAN DIEGO, April 9, 2024 /PRNewswire/ — GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, today announced the latest findings of GFH547, an oral panRAS (ON) inhibitor, […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

GenFleet Therapeutics Announces Potent Anti-tumor Efficacy of GFH375, an Oral KRAS G12D (ON/OFF) Inhibitor, and its Potential in Combination Therapy with RAF/MEK Clamp at 2024 AACR Annual Meeting

SHANGHAI and SAN DIEGO, April 9, 2024 /PRNewswire/ — GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, today unveiled the latest research findings of GFH375, an oral KRAS G12D […]

No Picture
News

Oral report | The positive interim analysis results from the Phase III clinical study of Akeso’s Cadonilimab (PD-1/CTLA-4 BsAb) plus chemotherapy as first-line treatment for advanced gastric cancer presented at 2024 AACR

SAN DIEGO, April 8, 2024 /PRNewswire/ — Akeso, Inc. (9926.HK) today announced that the positive interim analysis results from Phase III clinical study of Cadonilimab (PD-1/CTLA-4 BsAb) combined with XELOX (capecitabine plus oxaliplatin) as first-line […]

ADVERTISEMENT — Advertise With Biotech Networks
News

Element Biosciences Announces Availability of AVITI24, the First Benchtop Sequencer Capable of Direct Cell Profiling

Element’s new multi-omics platform will be shipped by end of the year AVITI24 offers an unprecedented view of cells at the molecular and functional level SAN DIEGO, April 5, 2024 /PRNewswire/ — Element Biosciences, Inc., […]

No Picture
News

Independent European data on CP-GEP model in Stratifying Melanoma Patients for Long Term Survival

ROTTERDAM, Netherlands and SAN DIEGO, April 5, 2024 /PRNewswire/ — SkylineDx is pleased to announce two forthcoming scientific publications at the European Association for Dermato-Oncology congress, April 4-6, 2024. These publications show Merlin test’s (CP-GEP […]

ADVERTISEMENT — Advertise With Biotech Networks
News

IRBM to Disclose Strong Antitumor Efficacy of Novel Preclinical Agents Against Aggressive Brain Tumors and Acute Lymphoblastic Leukemia at AACR

ROME, April 4, 2024 /PRNewswire/ — IRBM, a leader in the field of drug discovery, announced today that it will be disclosing new data on two of its most promising internal assets at the upcoming […]

ADVERTISEMENT — Advertise With Biotech Networks
News

INTERACT COALITION FORMED TO ADVANCE PATIENT ACCESS TO GENETIC TESTING FOR HEREDITARY CANCER RISK

SAN DIEGO, April 3, 2024 /PRNewswire/ — Leading commercial organizations and patient advocacy groups in the field of cancer genetics today announced the founding of the Inter-Organization Cancer Genetics Clinical Evidence Coalition (INTERACT), a coalition […]

News

Neurocrine Biosciences Announces First-Patient Dosed in Phase 2 Clinical Study Evaluating NBI-1070770 in Adults with Major Depressive Disorder

SAN DIEGO, April 3, 2024 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that the first patient has been randomized for its Phase 2 clinical study to evaluate the efficacy, safety, and tolerability of […]